| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |